QC Laboratory Deviations

The incident began with a routine quality control analysis of a critical active pharmaceutical ingredient (API). Laboratory personnel observed that the initial runs of the assay displayed unusual variability in…

The issue first manifested when significant deviations were identified in routine testing results of Active Pharmaceutical Ingredients (APIs). Analysts noted discrepancies in the assay values from two consecutive batches. The…

During routine data review procedures in a QC laboratory, discrepancies were identified in the raw data recorded for potency analysis of an active pharmaceutical ingredient (API). Analysts noticed that several…

During routine operational reviews, several key symptoms indicated a potential training gap among analysts during a method transfer:Click to read the full article.

Multiple indicators should signal a potential system suitability failure, particularly during routine analytical testing. In this case, employees in the QC laboratory noticed discrepancies in performance metrics during High-Performance Liquid…

The initial signal of an unauthorized method modification typically emerges during routine testing processes. In this case, a laboratory technician discovered discrepancies in test results for a quality control assay…

The initial symptoms of this deviation were observed during routine data integrity checks in the quality control laboratory. Analysts reported inconsistencies between reported results and raw data logs, inciting concerns…

Upon receiving a series of OOS results during routine quality control laboratory testing, it became evident that the laboratory was facing significant challenges. Specifically, the OOS results pertained to the…

During a routine internal audit in a QC laboratory, the inspection team noted discrepancies in the results from assays conducted by Analyst A. The discrepancies raised questions about the data…

The initial detection of the issue began with a deviation report from the quality control (QC) laboratory. Analysts reported inconsistencies in test results of a critical drug product. Further examination…

During routine quality control checks at a pharmaceutical manufacturing facility, personnel noticed discrepancies in test results of a critical active pharmaceutical ingredient (API). The laboratory data indicated several OOS results,…

The first step towards managing a deviation is recognizing its symptoms. In this case, laboratory analysts observed inconsistent results during routine Liquid Chromatography (LC) testing. The system suitability criteria specified…